137 related articles for article (PubMed ID: 35849476)
1. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials: Correction.
Obstet Gynecol; 2022 Jul; 140(1):138. PubMed ID: 35849476
[No Abstract] [Full Text] [Related]
2. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
Stewart EA; Lukes AS; Venturella R; Arjona Ferreira JC; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Obstet Gynecol; 2022 Jun; 139(6):1070-1081. PubMed ID: 35675604
[TBL] [Abstract][Full Text] [Related]
3. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
Obstet Gynecol; 2022 Dec; 140(6):920-930. PubMed ID: 36357960
[TBL] [Abstract][Full Text] [Related]
4. A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy.
Sasamori Y; Takehara K; Terashima T; Onodera T; Yatsuki K; Nakagawa I; Takahashi Y; Nishida H; Ichinose T; Hiraike H; Nagasaka K
BMC Womens Health; 2021 Aug; 21(1):306. PubMed ID: 34412607
[TBL] [Abstract][Full Text] [Related]
5. A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HO; Li Y; McKain L; Arjona Ferreira JC; Langenberg AG; Wagman RB; Stewart EA
Pain Manag; 2023 Apr; 13(4):205-211. PubMed ID: 37183454
[TBL] [Abstract][Full Text] [Related]
6. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of submucosal leiomyomas that could cause severe hemorrhage with relugolix: an observational study.
Wada Y; Takei Y; Minezumi T; Hirashima H; Fujiwara H
BMC Womens Health; 2023 Mar; 23(1):110. PubMed ID: 36922784
[TBL] [Abstract][Full Text] [Related]
8. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
Al-Hendy A; Lukes AS; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
J Comp Eff Res; 2023 Aug; 12(8):e230069. PubMed ID: 37477173
[TBL] [Abstract][Full Text] [Related]
9. Relugolix for the treatment of uterine fibroids.
Rocca ML; Palumbo AR; Lico D; Fiorenza A; Bitonti G; D'Agostino S; Gallo C; Di Carlo C; Zullo F; Venturella R
Expert Opin Pharmacother; 2020 Oct; 21(14):1667-1674. PubMed ID: 32674616
[TBL] [Abstract][Full Text] [Related]
10. Short-term administration of oral relugolix before single-port laparoscopic-assisted vaginal hysterectomy for symptomatic uterine myomas: A retrospective comparative study with leuprorelin injection.
Takeda A
J Obstet Gynaecol Res; 2022 Jul; 48(7):1921-1929. PubMed ID: 35460303
[TBL] [Abstract][Full Text] [Related]
11. Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.
Osuga Y; Enya K; Kudou K; Hoshiai H
Fertil Steril; 2019 Nov; 112(5):922-929.e2. PubMed ID: 31594635
[TBL] [Abstract][Full Text] [Related]
12. Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.
Hoshiai H; Seki Y; Kusumoto T; Kudou K; Tanimoto M
BMC Womens Health; 2021 Oct; 21(1):375. PubMed ID: 34711224
[TBL] [Abstract][Full Text] [Related]
13. Relugolix - new treatment for uterine fibroid-related heavy bleeding.
Baird DD; Harmon QE
Nat Rev Endocrinol; 2021 Jun; 17(6):321-322. PubMed ID: 33854216
[No Abstract] [Full Text] [Related]
14. Relugolix for the treatment of uterine fibroids.
Barra F; Seca M; Della Corte L; Giampaolino P; Ferrero S
Drugs Today (Barc); 2019 Aug; 55(8):503-512. PubMed ID: 31461087
[TBL] [Abstract][Full Text] [Related]
15. A case of acute abdominal pain caused by infarcted parasitic leiomyoma.
Yoo Jung L; Lee YH; Chung DH; Shin JW
J Obstet Gynaecol; 2020 Jan; 40(1):143-144. PubMed ID: 31303087
[No Abstract] [Full Text] [Related]
16. Relugolix and elagolix directly inhibit leiomyoma extracellular matrix production in 2-dimesnional and 3-dimensional cell cultures.
Wright D; Britten J; Malik M; Catherino WH
F S Sci; 2022 Aug; 3(3):299-308. PubMed ID: 35977805
[TBL] [Abstract][Full Text] [Related]
17. A large symptomatic leiomyoma of the round ligament.
Vignali M; Bertulessi C; Spreafico C; Busacca M
J Minim Invasive Gynecol; 2006; 13(5):375-6. PubMed ID: 16962517
[No Abstract] [Full Text] [Related]
18. [Unusual complication of uterine leiomyoma: spontaneous avulsion with massive hemoperitoneum].
Pachy F; Lemercier D; Dommergues M; Sibony O
J Gynecol Obstet Biol Reprod (Paris); 2009 May; 38(3):239-41. PubMed ID: 19179018
[TBL] [Abstract][Full Text] [Related]
19. [Thrombopenia associated with a case of uterine leiomyoma. Recovery after hysterectomy].
Dine G; Dupoirieux J; Hopfner C; Duhamel G
Presse Med; 1984 Jun; 13(23):1459. PubMed ID: 6233600
[No Abstract] [Full Text] [Related]
20. Non-puerperal incomplete lateral uterine inversion with submucous leiomyoma: a case report.
Mayadeo NM; Tank PD
J Obstet Gynaecol Res; 2003 Aug; 29(4):243-5. PubMed ID: 12959146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
